Abstract
One-hundred and thirty confirmed cases of severe acute respiratory syndrome (SARS) were recruited to evaluate their anti-SARS-coronavirus (CoV) antibody status and human leukocyte antigen (HLA) types in September 2006, 3 y after the SARS outbreaks in Taiwan. Western blot assay showed that 6.9% of participants still had anti-spike and anti-nucleocapside antibodies. A case-control study of the association of HLA with SARS revealed that the HLA-Cw1502 and DR0301 alleles conferred resistance against SARS infection (p<0.05).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antibodies, Neutralizing / blood
-
Antibodies, Viral / blood*
-
Asian People / genetics*
-
Case-Control Studies
-
Disease Resistance / genetics*
-
Disease Resistance / immunology
-
Female
-
Genotype
-
HLA-C Antigens / genetics*
-
HLA-DR3 Antigen / genetics*
-
Histocompatibility Testing
-
Humans
-
Male
-
Severe Acute Respiratory Syndrome / epidemiology
-
Severe Acute Respiratory Syndrome / genetics*
-
Severe Acute Respiratory Syndrome / immunology
-
Severe acute respiratory syndrome-related coronavirus / immunology
-
Severe acute respiratory syndrome-related coronavirus / pathogenicity
-
Taiwan / epidemiology
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
HLA-C Antigens
-
HLA-DR0301 antigen
-
HLA-DR3 Antigen